Promega Corporation said that its GoTaq Probe 1-Step RT-qPCR System is now available in Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use. Available through the CDC’s Emergency Use Authorization (EUA), the Promega tool is an approved master mix option for the 2019-Novel Coronavirus Real-Time RT-PCR Diagnostic Panel of the CDC. Recently, […]
Continue reading …Johnson & Johnson coronavirus vaccine targeted to be launched in early 2021
March 31, 2020 No Comment
Johnson & Johnson said that it has selected a lead coronavirus vaccine candidate from constructs it has been working on since the start of this year, which it aims to bring it to the market in early 2021 through emergency use authorization. The company, in this connection, said that its subsidiary Janssen Pharmaceutical has significantly […]
Continue reading …
The UK’s Medical Research Council has granted £5 million collectively to the University of Liverpool, the Imperial College London, and the University of Edinburgh to handle the coronavirus outbreak from the government’s rapid response call. This investment in Urgent Public Health Research is necessary to understand COVID-19 as well as its impact on the human […]
Continue reading …
Abbott ID NOW COVID-19 test : Medical device company Abbott has been granted Emergency Use Authorization (EUA) for its five-minute novel coronavirus diagnostic test from the US Food and Drug Administration (FDA). The company has launched the coronavirus detection test following the FDA approval. According to Abbott, the ID NOW platform is the fastest available […]
Continue reading …behold.ai red dot algorithm identifies chest x-rays of coronavirus patients as abnormal
March 28, 2020 No Comment
behold.ai claimed that its artificial intelligence-based red dot algorithm has been shown to have quickly identified chest X-rays from COVID-19 patients as ‘abnormal’. The UK-based healthtech company expects the ‘instant triage’ to enable an expedited diagnosis of novel coronavirus cases and ensure resources are properly allocated. According to behold.ai, its red dot algorithm was trained […]
Continue reading …
BioDuro said that it has launched a COVID-19 nanobody therapeutic program by leveraging its biologics discovery platform, which makes use of artificial intelligence computing and high-speed DNA mutagenesis technology. The life sciences contract research and development organization expects to screen over 10 billion human synthetic antibodies generated by its technology platform. BioDuro said that its […]
Continue reading …RECOVERY coronavirus trial : First patients enrolled in COVID-19 clinical trial by University of Oxford
March 26, 2020 No Comment
RECOVERY coronavirus trial : University of Oxford researchers in the UK have initiated a coronavirus clinical trial called the Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial. The RECOVERY clinical trial, which has enrolled the first patients, will test the effects of potential drug treatments for COVID-19 patients admitted to hospitals. The objective of the clinical […]
Continue reading …
A new COVID-19 Genomics UK Consortium has been created with support from the UK government to map how the novel coronavirus spreads and behaves by using whole-genome sequencing. The University of Liverpool is the newest member to join the consortium which is said to include the UK’s leading clinicians and scientists. The consortium backed by […]
Continue reading …Coronavirus vaccine trial : Moderna doses first subject with mRNA-1273 in phase 1 trial
March 17, 2020 No Comment
Coronavirus vaccine trial : US biotech company Moderna has dosed the first participant in the phase 1 study of mRNA-1273, its mRNA vaccine against the novel coronavirus (SARS-CoV-2). The phase 1 coronavirus clinical trial is being carried out under its own Investigational New Drug (IND) application by the National Institutes of Health (NIH). mRNA-1273 is […]
Continue reading …
Thermo Fisher Scientific has been granted an emergency use authorization (EUA) for its coronavirus diagnostic test from the US Food and Drug Administration (FDA). The FDA authorization allows Thermo Fisher Scientific’s COVID-19 diagnostic test that can be immediately used by CLIA high-complexity laboratories in the US for the detection of nucleic acid from SARS-CoV-2, the […]
Continue reading …
Business News Today
- Campari Group to acquire stake in online wines and spirits company Tannico
- Munich Re’s ERGO to buy 25% stake in China-based Taishan Insurance
- Abu Dhabi’s ADIA to invest $752m in Reliance’s Jio Platforms
- Orbital Science wins NASA Gateway contract to enable human habitation
- Nelson Global Products scraps deal to acquire Donaldson’s E&E business
- Collier Creek to acquire US salty snacks manufacturer Utz Quality Foods
- Bambuser to provide Live Video Shopping software to fashion retailer
- Macmahon wins contract extension at Byerwen coking coal mine in Queensland
- Cloud9 Technologies secures $17.5m funding for cloud-based communications
- Puig to buy majority stake in British cosmetics company Charlotte Tilbury
